Abstract
Arsenite (As+3) and dibenzo[def,p]chrysene (DBC), a polycyclic aromatic hyrdrocarbon (PAH), are found in nature as environmental contaminants. Both are known to individually suppress the immune system of humans and mice. In order to determine their potential interactive and combined immunosuppressive effects, we examined murine bone marrow (BM) immune progenitor cells’ responses following combined oral exposures at very low levels of exposure to As+3 and DBC. Oral 5-day exposure to DBC at 1 mg/kg (cumulative dose) was found to suppress mouse BM lymphoid progenitor cells, but not the myeloid progenitors. Previously established no-effect doses of As+3 in drinking water (19 and 75 ppb for 30 days) produced more lymphoid suppression in the bone marrow when mice were concomitantly fed a low dose of DBC during the last 5 days. The lower dose (19 ppb) As+3 had a stronger suppressive effect with DBC than the higher dose (75 ppb). Thus, the interactive toxicity of As+3 and DBC in vivo could be As+3 dose dependent. In vitro, the suppressive interaction of As+3 and DBC was also evident at low concentrations (0.5 nM), but not at higher concentrations (5 nM) of As+3. These studies show potentially important interactions between As+3 and DBC on mouse BM at extremely low levels of exposure in vivo and in vitro.



Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Argos M, Kalra T, Rathouz PJ, Chen Y, Pierce B, Parvez F, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Slavkovich V, van Geen A, Graziano J, Ahsan H (2010) Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 376:252–258
Kozul CD, Ely KH, Enelow RI, Hamilton JW (2009) Low-dose arsenic compromises the immune system response to influenza A infection in vivo. Environ Health Perspect 117:1441–1447
N’jai AU, Larsen M, Shi L, Jefcoate CR, Czuprynski JC (2010) Bone marrow lymphoid and myeloid progenitor cells are suppressed in 7,12-dimethylbenz(a)anthracene (DMBA) treated mice. Toxicology 271:27–35
Li Q, Lauer FT, Liu KJ, Hudson LG, Burchiel SW (2010) Low-dose synergistic immunosuppression of T-dependent antibody responses by polycyclic aromatic hydrocarbons and arsenic in C57BL/6J murine spleen cells. Toxicol Appl Pharmacol 245:344–351
Burchiel SW, Lauer FT, Beswick EJ, Gandolfi AJ, Parvez F, Liu KJ, Hudson LG (2014) Differential susceptibility of human peripheral blood T cells to suppression by environmental levels of sodium arsenite and monomethylarsonous acid. PLoS One 9:e109192
Ezeh PC, Lauer FT, MacKenzie D, McClain S, Liu KJ, Hudson LG, Gandolfi AJ (2014) Arsenite selectively inhibits mouse bone marrow lymphoid progenitor cell development in vivo and in vitro and suppresses humoral immunity in vivo. PLoS One 9:e93920
Gao J, Lauer FT, Dunaway S, Burchiel SW (2005) Cytochrome P450 1B1 is required for 7,12-dimethylbenz(a)anthracene (DMBA) induced spleen cell immunotoxicity. Toxicol Sci 86:68–74
Gao J, Lauer FT, Mitchell LA, Burchiel SW (2007) Microsomal expoxide hydrolase is required for 7,12-dimethylbenz[a]anthracene (DMBA) induced immunotoxicity in mice. Toxicol Sci 98:137–144
Gao J, Mitchell LA, Lauer FT, Burchiel SW (2008) p53 and ATM/ATR regulate 7,12-dimethyl-benz(a)anthracene-induced immunotoxicity. Mol Pharmacol 73:137–146
Lauer FT, Walker MK, Burchiel SW (2013) Oral exposure to dibenzo[def,p]chrysene (DBC) suppresses antibody formation in murine spleen cells. J Toxicol Environ Health 76:16–24
Galván N, Jaskula-Sztul R, MacWilliams PS, Czuprynski CJ, Jefcoate CR (2003) Bone marrow cytotoxicity of benzo[a]pyrene is dependent on CYP1B1 but is diminished by Ah receptor-mediated induction of CYP1A1 in liver. Toxicol Appl Pharmacol 193:84–96
Galván N, Page TJ, Czuprynski CJ, Jefcoate CR (2006) Benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene differentially affect bone marrow cells of the lymphoid and myeloid lineages. Toxicol Appl Pharmacol 213:105–116
Zhou X, Sun X, Cooper KL, Wang F, Liu KJ, Hudson LG (2011) Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs. J Biol Chem 286:22855–22863
Qin XJ, Liu W, Li YN, Sun X, Hai CX, Hudson LG, Liu KJ (2012) Poly (ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. Toxicol Sci 127:120–129
Siddens LK, Larkin A, Krueger SK, Bradfield CA, Waters KM, Tilton SC, Pereira CB, Löhr CV, Arlt VM, Phillips DH, Williams DE, Baird WM (2012) Polycyclic aromatic hydrocarbons as skin carcinogens: comparison of benzo[a]pyrene, dibenzo[def, p]chrysene and three environmental mixtures in the FVB/N mouse. Toxicol Appl Pharmacol 264:377–386
Crowell SR, Hanson-Drury S, Williams DE, Corley RA (2014) In vitro metabolism of benzo[a]pyrene and dibenzo[def,p]chrysene in rodent and human hepatic microsomes. Toxicol Lett 228:48–55
Cavalieri EL, Higginbotham S, RamaKrishna NV, Devanesan PD, Todorovic R, Rogan EG, Salmasi S (1991) Comparative dose–response tumorigenicity studies of dibenzo[alpha, l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benz[alpha, l]-pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis 12:1939–1944
Courter LA, Pereira C, Baird WM (2007) Diesel exhaust influences carcinogenic PAH-induced genotoxicity and gene expression in human breast epithelial cells in culture. Mutat Res 625:72–82
Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74:289–299
Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, Ma M, Yip L, Zakharyyan RA, Maiorino RM, Dart RC, Tircus MG, Gonzalez-Ramirez D, Morgan DL, Avram D, Aposhian MM (2000) Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 13:693–697
Jacobs JM, Nichols CE, Andrew AS, Marek DE, Wood SG, Sinclair PR, Wrighton SA, Kostrubsky VE, Sinclair JF (1999) Effect of arsenite on induction of CYP1A, CYP2B, and CYP3A in primary cultures of rat hepatocytes. Toxicol Appl Pharmacol 157:51–59
Vernhet L, Allain N, Le Vée M, Morel F, Guillouzo A, Fardel O (2003) Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons. J Pharmacol Exp Ther 304:145–155
Spink DC, Katz BH, Hussain MM, Spink BC, Wu SJ, Liu N, Pause R, Kaminsky LS (2002) Induction of CYP1A1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite. Drug Metab Dispos 30:262–269
Bessette EE, Fasco MJ, Pentecost BT, Kaminsky LS (2005) Mechanisms of arsenite-mediated decreases in benzo[k]fluoranthene-induced human cytochromeP4501A1 levels in HEPG2 cells. Drug Metab Dispos 33:312–320
Acknowledgments
Funding for this work was provided by the National Institute of Health (RO1 ES019968) and by the Southwest Environmental Health Sciences Center (P30 ES006694). The authors are grateful to Dr. Terry Monks at the University of Arizona for providing the MMA+3 used in this study and Dr. David Williams of Oregon State University for providing the DBC-diol.
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving animals were in accordance with the ethical standards of the University of New Mexico Institutional Animal Care and Use Committee (IACUC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ezeh, P.C., Lauer, F.T., Liu, K.J. et al. Arsenite Interacts with Dibenzo[def,p]chrysene (DBC) at Low Levels to Suppress Bone Marrow Lymphoid Progenitors in Mice. Biol Trace Elem Res 166, 82–88 (2015). https://doi.org/10.1007/s12011-015-0279-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-015-0279-6


